So how do you respond to that and how does the series address it?

Well, that's a very legitimate concern.

It's something we discussed extensively as a writing group.

We had representation from many different disciplines, including primary care.

And our goal isn't to label normal aging as a disease or turn healthy people into patients.

And I think one way to think about it is through the lens of cardiovascular disease.

We routinely measure cholesterol and other risk markers, not because everyone with elevated cholesterol is destined to have a heart attack, but because those help identify individuals who are at higher risk, who may benefit from closer monitoring or even intervention.

So what's the value of setting out a workflow now while that evidence is still being gathered?